§4.100. Application of the general rating formula for diseases of the heart.
38 C.F.R. § 4.100
Whether or not cardiac hypertrophy or dilatation (documented by electrocardiogram, echocardiogram, or X-ray) is present and whether or not there is a need for continuous medication must be ascertained in all cases.
Even if the requirement for a 10% (based on the need for continuous medication) or 30% (based on the presence of cardiac hypertrophy or dilatation) evaluation is met, METs testing is required in all cases except:
When there is a medical contraindication.
When a 100% evaluation can be assigned on another basis.
Notes, amendments, and revision history
Amendments
[71 FR 52460, Sept. 6, 2006, as amended at 86 FR 54093, Sept. 30, 2021; 86 FR 67654, Nov. 29, 2021]
Authority
Authority: 38 U.S.C. 1155, unless otherwise noted.
Source
Source: 29 FR 6718, May 22, 1964, unless otherwise noted.
Amendments
[71 FR 52460, Sept. 6, 2006, as amended at 86 FR 54093, Sept. 30, 2021; 86 FR 67654, Nov. 29, 2021]